No Benefit of Colchicine After Stroke, TIA: CHANCE-3 : vimar

The anti-inflammatory agent, started within 24 hours of acute ischemic stroke or TIA, did not reduce subsequent stroke or other vascular events at 90 days in the CHANCE-3 trial.

Related Keywords

China , Toronto , Ontario , Canada , Chinese , Yongjun Wang , Ashkan Shoamanesh , National Institutes Of Health Stroke Scale , Mcmaster University , World Stroke Congress , Capital Medical University , Beijing Tiantan Hospital , National Institutes , Health Stroke Scale , Modified Rankin Scale , Medscape Cardiology , Stroke , Erebrovascular Accident , Va Cerebrovascular Accident , Thromboembolism , Ischemic Stroke , Anti Inflammatory Agents , Atherosclerotic Heart Disease , Therosclerotic Cardiovascular Disease , Oronary Heart Disease , Schemic Heart Disease , Transient Ischemic Attack , Cia , Cv , Ardiovascular , Atherosclerosis , Cerebrovascular Disease ,